124 related articles for article (PubMed ID: 10083618)
21. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.
Stuart PM; Griffith TS; Usui N; Pepose J; Yu X; Ferguson TA
J Clin Invest; 1997 Feb; 99(3):396-402. PubMed ID: 9022072
[TBL] [Abstract][Full Text] [Related]
22. Effect of Neoral or cyclosporine on the development of chronic rejection in an aortic allograft rat model.
Little DM; Stoltenberg RL; Hullett DA; Sollinger HW
Transplant Proc; 1996 Apr; 28(2):880-1. PubMed ID: 8623445
[No Abstract] [Full Text] [Related]
23. Increased expression of transforming growth factor-beta during chronic rejection.
Walgenbach KJ; Heeckt PF; Stanson JD; Whiteside TL; Bauer AJ
Transplant Proc; 1996 Oct; 28(5):2450. PubMed ID: 8907892
[No Abstract] [Full Text] [Related]
24. Intimal thickening develops without humoral immunity in a mouse aortic allograft model of chronic vascular rejection.
Chow LH; Huh S; Jiang J; Zhong R; Pickering JG
Circulation; 1996 Dec; 94(12):3079-82. PubMed ID: 8989111
[TBL] [Abstract][Full Text] [Related]
25. Membrane Fas ligand activates innate immunity and terminates ocular immune privilege.
Gregory MS; Repp AC; Holhbaum AM; Saff RR; Marshak-Rothstein A; Ksander BR
J Immunol; 2002 Sep; 169(5):2727-35. PubMed ID: 12193747
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of rejection of nonvascularized grafts: the role of perforin and Fas.
Selvaggi G; Ricordi C; Podack E; Inverardi L
Transplant Proc; 1997 Jun; 29(4):2075-6. PubMed ID: 9193534
[No Abstract] [Full Text] [Related]
27. Immunohistochemical analysis in the extracellular matrix during acute rejection of small bowel grafts in rats.
Fujisaki S; Kimizuka K; Park E; Tomita R; Fukuzawa M; Matsumoto K
Transplant Proc; 2000 Sep; 32(6):1316-7. PubMed ID: 10995964
[No Abstract] [Full Text] [Related]
28. Increase of interleukin-6 in the intestinal mucosa and muscularis following chronic rejection after small bowel transplantation.
Walgenbach KJ; Heeckt PF; Kalff JC; Stanson J; Whiteside TL; Hirner A; Bauer AJ
Transplant Proc; 1998 Sep; 30(6):2600. PubMed ID: 9745508
[No Abstract] [Full Text] [Related]
29. Acute rejection of rat renal allografts is influenced by the presence of a native kidney.
Grau V; Herbst B; Steiniger B
Transplant Proc; 1997 May; 29(3):1723. PubMed ID: 9142247
[No Abstract] [Full Text] [Related]
30. Skin graft rejection elicited by beta 2-microglobulin as a minor transplantation antigen involves multiple effector pathways: role of Fas-Fas ligand interactions and Th2-dependent graft eosinophil infiltrates.
Surquin M; Le Moine A; Flamand V; Nagy N; Rombaut K; Demoor FX; Stordeur P; Salmon I; Guéry JC; Goldman M; Abramowicz D
J Immunol; 2002 Jul; 169(1):500-6. PubMed ID: 12077281
[TBL] [Abstract][Full Text] [Related]
31. Critical role of Fas/Fas ligand interaction in CD28-independent pathway of allogeneic murine hepatocyte rejection.
Kawahara T; Kasai S; Yagita H; Sawa M; Kato K; Azuma M; Nakajima A; Okumura K; Futagawa S; Mito M
Hepatology; 1997 Oct; 26(4):944-8. PubMed ID: 9328317
[TBL] [Abstract][Full Text] [Related]
32. Differential effect of an anti-CD8 monoclonal antibody on rejection of murine intestine and cardiac allografts.
He G; Kim OS; Thistlethwaite JR; Hart J; Siegel CT; Szot GL; Newell KA
Transplant Proc; 1999; 31(1-2):1239-41. PubMed ID: 10083553
[No Abstract] [Full Text] [Related]
33. Involvement of Fas and Fas ligand interaction in allogeneic hepatocyte rejection in the spleen.
Kawahara T; Kasai S; Yagita H; Kato K; Sawa M; Nakajima A; Azuma M; Okumura K; Futagawa S; Mito M
Transplant Proc; 1997 Jun; 29(4):2187-8. PubMed ID: 9193582
[No Abstract] [Full Text] [Related]
34. Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants.
Yamagami S; Kawashima H; Tsuru T; Yamagami H; Kayagaki N; Yagita H; Okumura K; Gregerson DS
Transplantation; 1997 Oct; 64(8):1107-11. PubMed ID: 9355824
[TBL] [Abstract][Full Text] [Related]
35. A comparison of gene expression in murine cardiac allografts and isografts by means DNA microarray analysis.
Saiura A; Mataki C; Murakami T; Umetani M; Wada Y; Kohro T; Aburatani H; Harihara Y; Hamakubo T; Yamaguchi T; Hasegawa G; Naito M; Makuuchi M; Kodama T
Transplantation; 2001 Jul; 72(2):320-9. PubMed ID: 11477360
[TBL] [Abstract][Full Text] [Related]
36. Fas and perforin cytotoxic pathways are not the major effector mechanisms in allogeneic resistance to bone marrow.
Baker M; Podack ER; Levy RB
Ann N Y Acad Sci; 1995 Dec; 770():368-9. PubMed ID: 8597377
[No Abstract] [Full Text] [Related]
37. Pathogen-associated molecular patterns sensitize macrophages to Fas ligand-induced apoptosis and IL-1 beta release.
Fukui M; Imamura R; Umemura M; Kawabe T; Suda T
J Immunol; 2003 Aug; 171(4):1868-74. PubMed ID: 12902488
[TBL] [Abstract][Full Text] [Related]
38. Endothelin-1 receptor blockade and its effect on chronic rejection.
Tang JL; Aitouche A; Subbotin V; Salam A; Sun H; Gandhi C; Valdivia LA; Fung JJ; Starzl TE; Rao AS
Transplant Proc; 1999; 31(1-2):1249. PubMed ID: 10083558
[No Abstract] [Full Text] [Related]
39. Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine.
Stoltenberg RL; Geraghty J; Steele DM; Kennedy E; Hullett DA; Sollinger HW
Transplantation; 1995 Nov; 60(9):993-8. PubMed ID: 7491707
[TBL] [Abstract][Full Text] [Related]
40. The role of the perforin and Fas pathways of cytotoxicity in skin graft rejection.
Selvaggi G; Ricordi C; Podack ER; Inverardi L
Transplantation; 1996 Dec; 62(12):1912-5. PubMed ID: 8990386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
